Adam Logal
CIK 1356197 · Sr. Vice President, CFO · last filed 2026-07-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$783.1K
Companies
4
Total Filings
40
Lifetime Open-Market Net
-$2.17M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OPK | Sr. Vice President, CFO | 563,396 | $1.39 | $783.1K | -$2.17M | 28 | 2026-07-28 |
| Xenetic Biosciences, Inc. (XBIOW) Delisted | Director | — | $17.54 | — | $0 | 5 | 2023-12-08 |
| XBIO | Director | — | $3.22 | — | $0 | 2 | 2018-11-30 |
| VBI Vaccines Inc/BC (VBIV) Delisted | Director | 1,250 | $0.07 | $82 | $0 | 4 | 2018-06-18 |
Recent Filings · Page 2 of 4
40 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-12-06 | Xenetic Biosciences, Inc. (XBIOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-03 | OPK | Grant (A) | — | $0 | EDGAR |
| 2019-05-10 | OPK | Buy (P) | +3,250 | $6.6K | EDGAR |
| 2018-11-30 | XBIO | Grant (A) | — | $0 | EDGAR |
| 2018-06-22 | OPK | Grant (A) | — | $0 | EDGAR |
| 2018-06-18 | VBI Vaccines Inc/BC (VBIV) Delisted | Exer (M) | +12,500 | $0 | EDGAR |
| 2018-06-12 | OPK | Mixed | +11,054 | -$15.2K | EDGAR |
| 2018-03-14 | OPK | Buy (P) | +2,065 | $7.0K | EDGAR |
| 2018-01-25 | VBI Vaccines Inc/BC (VBIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-13 | XBIO | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.